Drugs and dementia

Pharmacotherapy and decision making by primary caregivers

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

Original languageEnglish
Title of host publicationEthical Foundations of Palliative Care for Alzheimer Disease
PublisherThe Johns Hopkins University Press
Pages330-342
Number of pages13
ISBN (Print)0801878705, 9780801898396
StatePublished - 2010

Fingerprint

Pharmacotherapy
Therapy
Drugs
Dementia
Caregivers
Decision Making
Person
Alzheimer's Disease
Ethical Issues
Empirical Research

All Science Journal Classification (ASJC) codes

  • Arts and Humanities(all)

Cite this

Haddad, A. M. (2010). Drugs and dementia: Pharmacotherapy and decision making by primary caregivers. In Ethical Foundations of Palliative Care for Alzheimer Disease (pp. 330-342). The Johns Hopkins University Press.

Drugs and dementia : Pharmacotherapy and decision making by primary caregivers. / Haddad, Amy M.

Ethical Foundations of Palliative Care for Alzheimer Disease. The Johns Hopkins University Press, 2010. p. 330-342.

Research output: Chapter in Book/Report/Conference proceedingChapter

Haddad, AM 2010, Drugs and dementia: Pharmacotherapy and decision making by primary caregivers. in Ethical Foundations of Palliative Care for Alzheimer Disease. The Johns Hopkins University Press, pp. 330-342.
Haddad AM. Drugs and dementia: Pharmacotherapy and decision making by primary caregivers. In Ethical Foundations of Palliative Care for Alzheimer Disease. The Johns Hopkins University Press. 2010. p. 330-342
Haddad, Amy M. / Drugs and dementia : Pharmacotherapy and decision making by primary caregivers. Ethical Foundations of Palliative Care for Alzheimer Disease. The Johns Hopkins University Press, 2010. pp. 330-342
@inbook{f65aa62953764da68fb08625acfa7bd7,
title = "Drugs and dementia: Pharmacotherapy and decision making by primary caregivers",
abstract = "The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.",
author = "Haddad, {Amy M.}",
year = "2010",
language = "English",
isbn = "0801878705",
pages = "330--342",
booktitle = "Ethical Foundations of Palliative Care for Alzheimer Disease",
publisher = "The Johns Hopkins University Press",

}

TY - CHAP

T1 - Drugs and dementia

T2 - Pharmacotherapy and decision making by primary caregivers

AU - Haddad, Amy M.

PY - 2010

Y1 - 2010

N2 - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

AB - The overall aim of this chapter is to review the literature regarding the experiences of primary caregivers (i.e., family members who care for a person with Alzheimer disease) and decisions about drug therapy. Specifically, the purpose is to describe the experience of acetylcholinesterase inhibitor (AChEI) therapy of primary caregivers of persons with Alzheimer disease (AD), outline the inherent ethical issues that are part of drug therapy decisions, and suggest areas for future, empirical research.

UR - http://www.scopus.com/inward/record.url?scp=33749334230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749334230&partnerID=8YFLogxK

M3 - Chapter

SN - 0801878705

SN - 9780801898396

SP - 330

EP - 342

BT - Ethical Foundations of Palliative Care for Alzheimer Disease

PB - The Johns Hopkins University Press

ER -